We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New 4D Flow Software Platform Showcased

By Andrew Deutsch
Posted on 07 Dec 2016
Print article
Image: An image generated by the 4D Arterys cardiac flow quantification software (Photo courtesy of Arterys).
Image: An image generated by the 4D Arterys cardiac flow quantification software (Photo courtesy of Arterys).
A company developing cloud-based medical imaging software has received 510(k) clearance from US FDA for its 4D cardiac flow quantification software.

The software was showcased at the annual Radiological Society of North America (RSNA 2016) meeting. The company also presented new information about clinical applications that use the 4-D flow software.

The Arterys 4D Flow software was developed by Arterys (San Francisco, CA, USA), a company that develops quantitative imaging tools for supporting treatment decisions. The Arterys 4D Flow platform uses cloud computing and advanced analytics techniques.

The 4D cardiac flow quantification technique uses phase-contrast Cardiac Magnetic Resonance (CMR) 3D data that is velocity-encoded in three spatial directions. The data is resolved relative to the 3 spatial dimensions, and time, for the duration of the cardiac cycle, and enables clinicians to visualize, and measure blood patterns in the 3D volume. The 4D Flow sequence is faster and simpler than conventional MRI scans.

CEO of Arterys, Fabien Beckers, said, "This year, RSNA is focusing a lot of attention on breakthrough technological developments that are moving medical imaging into a new era where it's possible to analyze data to help diagnose conditions much quicker, align various stakeholders in the health ecosystem, and mobilize on personalized treatment paths. We believe the Arterys platform will transform clinical practice through powerful, quantitative imaging tools that rapidly generate and analyze unprecedented amounts of data and insights that can support treatment decisions and the delivery of patient care."

Related Links:
Arterys

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Breast Imaging Workstation
SecurView
New
Ultrasound System
P20 Elite

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more